Drug · DIN 02478374
ERLEADA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 27, 2018; first marketed July 27, 2018.
- Drug Identification Number (DIN)
- 02478374
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Apalutamide L02BB05
- Class
- Human
- Record last updated
- September 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APALUTAMIDE | 60 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 3, 2018: NOC 21043New Drug Submission (NDS)
Other DINs named ERLEADA
- DIN 02540185 · Marketed